Announcements Trials
Browse Landscape

Phase

Phase NA 29Phase 2 3Phase 3 2Phase EARLY_PHASE1 1Phase 2/3 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Breast 1

Conditions

Breast Neoplasms 1214Triple Negative Breast Neoplasms 281Ovarian Neoplasms 261Carcinoma, Non-Small-Cell Lung 247Colorectal Neoplasms 188Pancreatic Neoplasms 168Stomach Neoplasms 163Neoplasm Metastasis 156Neoplasms 155Lung Neoplasms 144Prostatic Neoplasms 143Melanoma 132Carcinoma, Renal Cell 102Squamous Cell Carcinoma of Head and Neck 101Endometrial Neoplasms 98Head and Neck Neoplasms 88Colonic Neoplasms 82Urinary Bladder Neoplasms 79Uterine Cervical Neoplasms 76Esophageal Neoplasms 75Sarcoma 71Breast Neoplasms, Male 68Small Cell Lung Carcinoma 65Carcinoma, Hepatocellular 59Carcinoma, Ovarian Epithelial 58Kidney Neoplasms 47Carcinoma, Transitional Cell 40Rectal Neoplasms 35Fallopian Tube Neoplasms 34Liver Neoplasms 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Cognitive Dysfunction × Breast × Clear all
NCT00387062 2008-06-24

Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment

Posit Science Corporation

Phase 1 Completed
50 enrolled
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Memory Disorders, Neurobehavioral Manifestations, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡